Invesco S&P 500 Equal Weight Health Care ETF
RYH
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Invesco S&P 500 Equal Weight Health Care ETF (RYH) is an exchange-traded fund that tracks the S&P 500 Equal Weight Health Care Index, providing investors with equal-weighted exposure to healthcare sector companies within the S&P 500 universe. The ETF offers diversified access to large-cap U.S. healthcare equities across subsectors including pharmaceuticals, biotechnology, healthcare providers, life sciences tools and services, and health care equipment and supplies; its portfolio holdings encompass major constituents such as Eli Lilly & Co., UnitedHealth Group Inc., Johnson & Johnson, Merck & Co. Inc., and AbbVie Inc., rebalanced quarterly to maintain equal weighting of approximately 60 stocks. Managed by Invesco Ltd., founded in 1935 and headquartered in Atlanta, Georgia, with global operations spanning the Americas, Europe, Asia-Pacific, and the Middle East, RYH serves institutional and retail investors seeking sector-specific growth, defensive qualities, and dividend income in the healthcare industry, which represents a key segment of the broader U.S. equity market. Launched in 2006, the ETF continues to operate without major structural changes, though it benefits from Invesco's ongoing enhancements to its ETF suite, including expanded active and thematic offerings amid rising demand for healthcare innovation exposure driven by aging demographics and biotechnological advancements. Recent developments include Invesco's strategic acquisitions, such as the 2023 purchase of OppenheimerFunds to bolster its active management capabilities, and partnerships like the collaboration with Oppenheimer to integrate Oppenheimer Rochester funds into its platform; additionally, Invesco announced expansions in ESG-integrated ETFs and launched new healthcare-focused products in 2024-2025 to complement passive equal-weight strategies like RYH. These initiatives reflect Invesco's focus on operational efficiency, cost reductions through scale, and adaptation to regulatory shifts in asset management, positioning RYH within a robust ecosystem of over 200 ETFs managing trillions in assets under management.